Psychosocial predictors of doping intentions and use in sport and exercise

Keywords: doping, meta-analysis, protective and risk factors In this blog we summarise the findings of a recent quantitative review of the literature (i.e., “meta-analysis”) we published in BJSM on psychosocial predictors of doping intention, doping use, and inadvertent doping in sport and exercise settings (1). This project was funded by the Partnership for Clean Competition. […]

Read More…

The Maria Sharapova drug story: What’s the evidence? Does Meldonium treat heart conditions and diabetes?

By David Nunan @DNunan79 Many have commented on the how, who, what and ethical implications following Maria Sharapova’s shock revelation of her failed drugs test. Few have looked in more depth at the why? The evidence for “why?” in this case falls in to two key areas. First is the evidence that Mildronate (or Meldonium) is indicated […]

Read More…

Can I tell you something? I’m doping…

By HP Dijkstra¹, N van Dyk², YO Schumacher¹ ¹Sports Medicine Department, Aspetar Qatar Orthopaedic and Sports Medicine Hospital, Doha, Qatar. ²Rehabilitation Department, Aspetar Qatar Orthopaedic and Sports Medicine Hospital, Doha, Qatar Doping in sport, particularly in track and field, is a reality.[1] [2] The World Anti-Doping Agency (WADA) condemned a rife doping culture in Russian […]

Read More…

Lance Armstrong: The Fall of a Hero

Guest blog by Professor Phillip Sparling Please see Professor Sparling’s related call to action. Here’s the link – a petition written to Lance Armstrong. I’m grieving.  October 2012 will forever be imprinted in my memory as the month of damning revelations and the demise of Lance Armstrong.  I’m not naïve about the use of drugs […]

Read More…